Elanco Animal Health Inc (ELAN) concluded trading on Thursday at a closing price of $16.41, with 3.65 million shares of worth about $59.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 42.20% during that period and on Thursday the price saw a gain of about 2.18%. Currently the company’s common shares owned by public are about 492.80M shares, out of which, 486.02M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 47 times over the past 12 months. They bought 979,041 shares in 23 of the transactions. In 24 selling transactions, insiders dumped 399,837 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 16.56, or with a gain of 2.18%. Stock saw a price change of 3.40% in past 5 days and over the past one month there was a price change of 10.88%. Year-to-date (YTD), ELAN shares are showing a performance of 10.13% which increased to 27.31% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $7.88 but also hit the highest price of $16.34 during that period. The average intraday trading volume for Elanco Animal Health Inc shares is 4.99 million. The stock is currently trading 7.51% above its 20-day simple moving average (SMA20), while that difference is up 11.98% for SMA50 and it goes to 41.85% higher than SMA200.
Elanco Animal Health Inc (NYSE: ELAN) currently have 492.80M outstanding shares and institutions hold larger chunk of about 98.67% of that.
The stock has a current market capitalization of $8.09B and its 3Y-monthly beta is at 1.30. It has posted earnings per share of -$2.32 in the same period. It has Quick Ratio of 1.48 while making debt-to-equity ratio of 0.96. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ELAN, volatility over the week remained 2.50% while standing at 2.84% over the month.
Analysts are in expectations that Elanco Animal Health Inc (ELAN) stock would likely to be making an EPS of $Elevai Labs, Inc. in the current quarter, while forecast for next quarter EPS is $0.73 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Eledon Pharmaceuticals, Inc. which is $eGain Corporation at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Enliven Therapeutics, Inc. in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -17.15% while it is estimated to decrease by -3.63% in next year. EPS is likely to shrink at an annualized rate of -1.80% for next 5-years, compared to annual growth of 28.42% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on January 05, 2024 offering a Buy rating for the stock and assigned a target price range of between $13 and $20 to it.
